Why does anybody own CRISPR? An argument against academic IP – MedCity News https://t.co/M46dUfriCq
— The Propell Group (@ThePropellGroup) March 19, 2017
#healthtech
Why does anybody own CRISPR? An argument against academic IP – MedCity News https://t.co/M46dUfriCq
— The Propell Group (@ThePropellGroup) March 19, 2017
#healthtech